Jump Financial, LLC Mereo Biopharma Group PLC Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.3 - $4.05 $290,950 - $512,325
126,500 New
126,500 $417,000
Q4 2021

Feb 10, 2022
SELL
$1.51 - $2.59 $49,509 - $84,920
-32,788 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$2.2 - $3.17 $261,606 - $376,951
-118,912 Reduced 78.39%
32,788 $79,000
Q2 2021

Aug 13, 2021
BUY
$2.94 - $4.08 $445,998 - $618,936
151,700 New
151,700 $481,000

Others Institutions Holding MREO

# of Institutions
85
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $441M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email